Editorial
doi: 10.1056/NEJMe0809343.
Targeted therapy for advanced colorectal cancer--more is not always better
- PMID: 19196680
- DOI: 10.1056/NEJMe0809343
Item in Clipboard
Editorial
Targeted therapy for advanced colorectal cancer--more is not always better
N Engl J Med.
.
No abstract available
Comment on
-
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.N Engl J Med. 2009 Feb 5;360(6):563-72. doi: 10.1056/NEJMoa0808268. N Engl J Med. 2009. PMID: 19196673 Clinical Trial.
Similar articles
-
Chemotherapy and immunotherapy in metastatic colorectal cancer.N Engl J Med. 2009 May 14;360(20):2135; author reply 2135-6. N Engl J Med. 2009. PMID: 19445032 No abstract available.
-
Chemotherapy and immunotherapy in metastatic colorectal cancer.N Engl J Med. 2009 May 14;360(20):2135; author reply 2135-6. N Engl J Med. 2009. PMID: 19445033 No abstract available.
-
Bevacizumab in advanced colorectal cancer: a challenge to the current paradigm.J Clin Oncol. 2008 Oct 1;26(28):4693-4; author reply 4694-5. doi: 10.1200/JCO.2008.18.8060. J Clin Oncol. 2008. PMID: 18824719 No abstract available.
-
[The development of the first line treatment of metastatic colorectal cancer (mCRC)].Magy Onkol. 2009 Sep;53(3):237-46. doi: 10.1556/MOnkol.53.2009.3.1. Magy Onkol. 2009. PMID: 19793687 Review. Hungarian.
-
Combined-modality therapy for rectal cancer: future prospects.Clin Colorectal Cancer. 2007 Sep;6(9):625-33. doi: 10.3816/CCC.2007.n.030. Clin Colorectal Cancer. 2007. PMID: 17945034 Review.
Cited by
-
Zinc Acts Synergistically with Berberine for Enhancing Its Efficacy as an Anti-cancer Agent by Inducing Clusterin-Dependent Apoptosis in HT-29 Colorectal Cancer Cells.Biol Trace Elem Res. 2023 Aug;201(8):3755-3773. doi: 10.1007/s12011-022-03460-8. Epub 2022 Nov 17. Biol Trace Elem Res. 2023. PMID: 36394793
-
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.Clin Transl Med. 2018 Mar 1;7(1):11. doi: 10.1186/s40169-018-0185-6. Clin Transl Med. 2018. PMID: 29541939 Free PMC article.
-
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists.J Clin Oncol. 2013 Mar 20;31(9):1134-9. doi: 10.1200/JCO.2012.42.7252. Epub 2013 Feb 19. J Clin Oncol. 2013. PMID: 23423747 Free PMC article.
-
Combined therapies for cancer: a review of EGFR-targeted monotherapy and combination treatment with other drugs.J Cancer Res Clin Oncol. 2009 Sep;135(9):1137-48. doi: 10.1007/s00432-009-0622-4. Epub 2009 Jun 17. J Cancer Res Clin Oncol. 2009. PMID: 19533170 Free PMC article. Review.
-
Cell therapies and regenerative medicine.Hepatol Int. 2014 Apr;8(2):158-65. doi: 10.1007/s12072-013-9512-6. Epub 2014 Jan 19. Hepatol Int. 2014. PMID: 26202498
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
